Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study-Reference-Cited by-同舟云学术

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

Published:2013-12-17 Issue:3 Volume:74 Page:526-531
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Mariette Xavier,Seror Raphaèle,Quartuccio Luca,Baron Gabriel,Salvin Sara,Fabris Martina,Desmoulins Frederic,Nocturne Gaétane,Ravaud Philippe,De Vita Salvatore

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference28 articles.

1. Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects;Tzioufas;J Autoimmun,2012

2. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients;Garcia-Carrasco;Medicine (Baltimore),2002

3. Treatment of primary Sjogren syndrome: a systematic review;Ramos-Casals;JAMA,2010

4. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry;Gottenberg;Ann Rheum Dis,2013

5. Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial;Meijer;Arthritis Rheum,2010

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Bone Density Changes and Fracture Risk in Myasthenia Gravis: Implications for FRAX® Tool Application;Healthcare;2024-09-08

2. Outcomes from a Multidisciplinary Otolaryngology and Rheumatology Clinic for the Management of Chronic Sialadenitis;Otolaryngology–Head and Neck Surgery;2024-09-03

3. Subpopulation dynamics of T and B lymphocytes in Sjögren’s syndrome: implications for disease activity and treatment;Frontiers in Immunology;2024-09-03

4. Primary Sjögren syndrome specific B cells induced aberrant surface aggregation of B cell receptors (BCRs) and signalling;Medical Hypotheses;2024-09

5. Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren’s disease;RMD Open;2024-08